Rallybio Corporation (RLYB)
NASDAQ: RLYB · IEX Real-Time Price · USD
1.200
-0.160 (-11.76%)
At close: Jul 2, 2024, 4:00 PM
1.320
+0.120 (10.00%)
After-hours: Jul 2, 2024, 7:50 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $49.74 million as of July 2, 2024. Its market cap has decreased by -78.15% in one year.
Market Cap
49.74M
Enterprise Value
-44.10M
1-Year Change
-78.15%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $49.74M, a decrease of -87.74%. That is a compound annual growth rate of -51.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 49.70M | -44.96% |
| Dec 29, 2023 | 90.30M | -57.10% |
| Dec 30, 2022 | 210.50M | -31.32% |
| Dec 31, 2021 | 306.50M | -24.43% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reneo Pharmaceuticals | 50.47M |
| Alpha Teknova | 50.21M |
| Milestone Scientific | 50.20M |
| Modular Medical | 50.11M |
| Bright Green | 49.98M |
| LAVA Therapeutics | 49.69M |
| Mobile-health Network Solutions | 49.30M |
| LENSAR | 49.12M |